Disclosed in the present specification are an anti-inflammatory composition containing a yeast-derived extracellular vesicle as an active ingredient, and an anti-inflammatory composition containing, as an active ingredient, a food-derived extracellular vesicle containing yeast. According to one aspect, the yeast may be Saccharomyces cerevisiae, and the anti-inflammatory composition has the effect of suppressing or inhibiting the secretion of Tumor necrosis factor-α (TNF-α) or Interleukin-6 (IL-6) which are inflammation-related media.La présente invention concerne une composition anti-inflammatoire contenant, en tant qu'ingrédient actif, une vésicule extracellulaire dérivée d'une levure, et une composition anti-inflammatoire contenant, en tant qu'ingrédient actif, de la levure contenant une vésicule extracellulaire dérivée d'un aliment. Selon un aspect, la levure peut être Saccharomyces cerevisiae, et la composition anti-inflammatoire a pour effet de supprimer ou d'inhiber la sécrétion du facteur de nécrose tumorale α (TNF-α) ou de l'interleukine-6 (IL-6) qui sont des substances liées à l'inflammation.본 명세서에는 효모 유래의 세포밖 소포체를 유효성분으로 포함하는 항염 조성물 및 효모를 포함하는 식품 유래의 세포밖 소포체를 유효성분으로 포함하는 항염 조성물이 개시된다. 일 측면에서, 상기 효모는 Saccharomyces cerevisiae일 수 있으며, 상기 항염 조성물은 염증 관련 매개체인 Tumor necrosis factor-α(TNF-α) 또는 Interleukin-6(IL-6)의 분비를 억제 또는 저해하는 효과가 있다.
